Thursday, May 11, 2017, at 1:00 p.m. (Eastern)
At least half of the 50 states have some form of legislation regarding the growth, distribution and use of marijuana for medical purposes, and four allow recreational use. The federal government still classifies marijuana as a Schedule 1 drug, dangerous and highly addictive, with no medical value. Despite the schizophrenic mindset, private investors are putting seed money to work. Join our panel to discuss when and how these investments might pay off.
In this session you will:
- Learn about the current political climate and how it may evolve to support this market.
- Find out who’s buying, who’s selling, and why.
- Discover which areas of the market have the strongest growth opportunities today.
- Learn about the investment timeline, and what could change in coming years.
PLUS… your chance to ask our panel of experts any questions about Medical Marijuana.
COST: Buy now for $297 per dial-in connection.
REGISTER TODAY for this unique webinar and learn about Medical Marijuana from our panel of leading industry experts — without ever having to leave your desk.
This educational offering is pending approval for 1.50 credit hours by the National Association of Long Term Care Administrator Boards (NAB). Upon webinar approval and enrollee’s successful completion of the test, Irving Levin Associates, Inc. will issue a NAB certificate of completion for students to issue to their state licensure boards.